Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EFNA1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | MBOAT1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | GPR3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | AGRN | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | PIK3C2G | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | PRSS27 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | ADORA2B | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | ACTBL2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | CCAR2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | AGR3 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |